Skip to main content
Log in

Impact of Long-Term Support with Berlin Heart EXCOR® in Pediatric Patients with Severe Heart Failure

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Berlin Heart EXCOR® (BHE) ventricular assist device (VAD) (Berlin Heart, Berlin Heart AG, Berlin, Germany) implantation is prevalent in patients with severe heart failure. However, clinical outcomes of pediatric patients on long-term BHE support remain mainly unknown. This study aimed to report our clinical experience with long-term support of pediatric patients with severe heart failure supported by BHE VAD. Clinical outcomes of 11 patients (median age 8.4 months; two male), who underwent LVAD implantation of the Berlin Heart EXCO® (BHE) VAD (Berlin Heart, Berlin Heart AG, Berlin, Germany) between 2013 and 2017 at our institution were reviewed. The median support period was 312 (range 45–661) days and five patients were supported for more than 1 year. The longest support duration was 661 days. No mortality occurred, and six patients were successfully bridged to heart transplantation, while three patients were successfully weaned off the device. Two patients are currently on BHE support while they await heart transplantation. Four patients had cerebral bleeding or infarction, but only one case of persistent neurological deficit occurred. No fatal device-related infection occurred during LVAD support. BHE VAD can provide long-term support for pediatric patients with severe heart failure with acceptable mortality and morbidity rates with long-term support.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hetzer R, Kaufmann F, Delmo Walter EM (2016) Paediatric mechanical circulatory support with Berlin Heart EXCOR: development and outcome of a 23-year experience. Eur J Cardiothorac Surg 50(2):203–210

    Article  Google Scholar 

  2. Conway J et al (2015) Delineating survival outcomes in children %3c10 kg bridged to transplant or recovery with the Berlin Heart EXCOR Ventricular Assist Device. JACC Heart Fail 3(1):70–77

    Article  Google Scholar 

  3. Hetzer R et al (2006) Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience. Semin Thorac Cardiovasc Surg 9(1):99–108

    Article  Google Scholar 

  4. Hetzer R et al (2011) Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg 141(3):616–623

    Article  Google Scholar 

  5. Di Molfetta A et al (2016) The use of Berlin Heart EXCOR VAD in children less than 10 kg: a single center experience. Front Physiol 7:614

    Article  Google Scholar 

  6. Almond CS et al (2011) Berlin Heart EXCOR Pediatric ventricular assist device investigational Device Exemption study: Study design and rationale. Am Hear J 162(3):425–435

    Article  Google Scholar 

  7. Isojima T et al (2016) Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endcrinol. 25(2):71–76

    Article  Google Scholar 

  8. Almond CS et al (2013) Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 127(16):1702–1711

    Article  CAS  Google Scholar 

  9. Morales DLS et al (2017) Berlin Heart EXCOR use in patients with congenital heart disease. J Heart Lung Transplant 36(11):1209–1216

    Article  Google Scholar 

  10. Byrnes JW et al (2013) Incremental reduction in the incidence of stroke in children supported with the Berlin EXCOR ventricular assist device. Ann Thorac Surg 96(5):1727–1733

    Article  Google Scholar 

  11. Miera O et al (2014) Pump size of Berlin Heart EXCOR pediatric device influences clinical outcome in children. J Heart Lung Transplant 33(8):816–821

    Article  Google Scholar 

  12. Jordan LC et al (2015) Neurological complications and outcomes in the Berlin Heart EXCOR(R) pediatric investigational device exemption trial. J Am Heart Assoc 4(1):e001429

    Article  Google Scholar 

  13. Zafar F et al (2015) Biventricular Berlin heart EXCOR pediatric use across the United States. Ann Thorac Surg 99(4):1328–1334

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiki Sawa.

Ethics declarations

Conflict of interest

None of the authors has any financial relationship related to this manuscript to disclose.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanaya, T., Ueno, T., Taira, M. et al. Impact of Long-Term Support with Berlin Heart EXCOR® in Pediatric Patients with Severe Heart Failure. Pediatr Cardiol 40, 1126–1133 (2019). https://doi.org/10.1007/s00246-019-02108-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-019-02108-0

Keywords

Navigation